Mostrar el registro sencillo del ítem

Artículo

dc.creatorBirgand, Gabrieles
dc.creatorMutters, Nico T.es
dc.creatorRaheelah, Ahmades
dc.creatorTacconelli, Evelinaes
dc.creatorLucet, Jean-Christophees
dc.creatorHolmes, Alisones
dc.creatorRodríguez-Baño, Jesúses
dc.date.accessioned2023-04-03T11:22:33Z
dc.date.available2023-04-03T11:22:33Z
dc.date.issued2020
dc.identifier.citationBirgand, G., Mutters, N.T., Raheelah, A., Tacconelli, E., Lucet, J., Holmes, . y Rodríguez Baño, J. (2020). Risk perception of antimicrobial resistance by infection control specialists in Europe: a case-vignette study. Antimicrobial Resistance and Infection Control, 9 (1). https://doi.org/10.1186/s13756-020-0695-z.
dc.identifier.issn2047-2994es
dc.identifier.urihttps://hdl.handle.net/11441/143875
dc.description.abstractBackground Using case-vignettes, we assessed the perception of European infection control (IC) specialists regarding the individual and collective risk associated with antimicrobial resistance (AMR) among inpatients. Methods In this study, sixteen case-vignettes were developed to simulate hospitalised patient scenarios in the field of AMR and IC. A total of 245 IC specialists working in different hospitals from 15 European countries were contacted, among which 149 agreed to participate in the study. Using an online database, each participant scored five randomly-assigned case-vignettes, regarding the perceived risk associated with six different multidrug resistant organisms (MDRO). The intra-class correlation coefficient (ICC), varying from 0 (poor) to 1 (perfect), was used to assess the agreement for the risk on a 7-point Likert scale. High risk and low/neutral risk scorers were compared regarding their national, organisational and individual characteristics. Results Between January and May 2017, 149 participants scored 655 case-vignettes. The perceptions of the individual (clinical outcome) and collective (spread) risks were consistently lower than other MDRO for extended spectrum beta-lactamase producing Enterobacteriaceae cases and higher for carbapenemase producing Enterobacteriaceae (CPE) cases. Regarding CPE cases, answers were influenced more by the resistance pattern (93%) than for other MDRO. The risk associated with vancomycin resistant Enterococci cases was considered higher for the collective impact than for the individual outcome (63% vs 40%). The intra-country agreement regarding the individual risk was globally poor varying from 0.00 (ICC: 0–0.25) to 0.51 (0.18–0.85). The overall agreement across countries was poor at 0.20 (0.07–0.33). IC specialists working in hospitals preserved from MDROs perceived a higher individual (local, p = 0.01; national, p < 0.01) and collective risk (local and national p < 0.01) than those frequently exposed to bacteraemia. Conversely, IC specialists working in hospitals with a high MDRO clinical burden had a decreased risk perception. Conclusions The perception of the risk associated with AMR varied greatly across IC specialists and countries, relying on contextual factors including the epidemiology. IC specialists working in high prevalence areas may underestimate both the individual and collective risks, and might further negatively promote the MDRO spread. These finding highlight the need to shape local and national control strategies according to risk perceptions and contextual factors.es
dc.formatapplication/pdfes
dc.format.extent10 p.es
dc.language.isoenges
dc.publisherNature Publishing Groupes
dc.relation.ispartofAntimicrobial Resistance and Infection Control, 9 (1).
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectEuropees
dc.subjectInfection prevention and controles
dc.subjectAntimicrobial resistancees
dc.subjectRisk perceptiones
dc.subjectCarbapenemase-producing Enterobacteriaceaees
dc.subjectMeticillin-resistant Staphylococcus aureuses
dc.subjectCarbapenemase-producing Pseudomonas aeruginosaes
dc.subjectCarbapenemase-producing Acinetobacter baumanniies
dc.subjectVancomycin-resistant Enterococcies
dc.titleRisk perception of antimicrobial resistance by infection control specialists in Europe: a case-vignette studyes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicinaes
dc.relation.publisherversionhttps://aricjournal.biomedcentral.com/articles/10.1186/s13756-020-0695-zes
dc.identifier.doi10.1186/s13756-020-0695-zes
dc.journaltitleAntimicrobial Resistance and Infection Controles
dc.publication.volumen9es
dc.publication.issue1es
dc.contributor.funderAntimicrobial Research Collaborative at Imperial College Londones
dc.contributor.funderESRC as part of the Antimicrobial Cross Council initiativees
dc.contributor.funderGlobal Challenges Research Fundes
dc.contributor.funderNational Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College Londones
dc.contributor.funderNIHR Fellowship in knowledge mobilisationes
dc.contributor.funderPublic Health England (PHE)es
dc.contributor.funderWelcome trustes

FicherosTamañoFormatoVerDescripción
Risk perception of antimicrobial ...1.060MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional